Very good start to the year – strong sales and earnings growth
11 May 2022, Leverkusen: The Bayer Group had a very successful start to 2022. “We achieved outstanding sales and earnings growth, with
Read MoreFind the latest news, research, product launches, financial results, investments, partnerships, regulatory developments, and business updates from Bayer. Stay informed on Crop Science, pharmaceuticals, consumer health, crop protection, seeds, biologicals, digital agriculture, healthcare, sustainability, and global business developments.
Bayer AG is a global life science company headquartered in Leverkusen, Germany, operating through three divisions: Crop Science, Pharmaceuticals, and Consumer Health. Its businesses develop products and technologies across agriculture and healthcare, with the company focused on addressing challenges related to food security, climate change, disease prevention, and healthcare access. Bayer’s global portfolio includes seeds, biotechnology traits, crop protection products, digital agriculture solutions, prescription medicines, and consumer healthcare brands.
The Crop Science division is particularly relevant to agriculture, with activities spanning seeds and traits, herbicides, fungicides, insecticides, biologicals, digital farming, and agricultural research. Bayer is advancing a pipeline of new agricultural products while focusing on technologies designed to improve farm productivity, resource efficiency, and resilience. Its current agricultural strategy includes a portfolio of ten planned blockbuster launches.
In India, Bayer has been present for more than 130 years and operates through businesses including Crop Science, Pharmaceuticals and Consumer Health. Bayer CropScience Limited is the group’s listed Indian Crop Science company, with activities covering crop protection, seeds, traits, biologicals and digital farming. The India Crop Science business works with more than 30 million smallholder farmers and focuses on crops including rice, corn, cotton, fruits and vegetables.
Bayer’s global developments in 2026 include Crop Science innovation, financial performance, product pipeline advancement, agricultural technology, sustainability, glyphosate litigation, and strategic investments. The company reported higher Crop Science sales and substantial earnings growth in both the first and second quarters of 2026.
This category features Bayer news, Crop Science, Bayer CropScience India, crop protection, seeds, herbicides, fungicides, insecticides, biologicals, digital agriculture, product launches, R&D, financial results, regulatory developments, sustainability, glyphosate, leadership, investments, partnerships, and global agriculture and healthcare developments.
11 May 2022, Leverkusen: The Bayer Group had a very successful start to 2022. “We achieved outstanding sales and earnings growth, with
Read More05 May 2022, Calgary, AB: By spending only five minutes online, charities and community programs or events could win one
Read More03 May 2022, AU: The foundation of this story is data – integrating and analysing complex and varied information on
Read More23 April 2022, Monheim: Projected transaction supports efforts to accelerate expansion of a diversified portfolio of high-quality microbial-based solutions for
Read More08 April 2022, China: Bayer Crop Science China launched fungicide fluopyram by the name Caimei in a product launch ceremony held
Read More29 March 2022, AU: Quigley Farms have been awarded the prestigious Bayer Cotton Grower of the Year Award for 2021. The
Read More22 March 2022, Calgary, AB: Are you a graduating Grade 12 student looking for a bit of help to finance
Read More17 March 2022, Germany: The Better Life Farming (BLF) Alliance has been launched in Latin America starting with the opening of
Read More10 March 2022, Leverkusen: Bayer and Cinven have entered into a definitive agreement regarding the sale of Bayer’s Environmental Science Professional
Read More03 March 2022, Germany: Bayer today announced changes in the leadership team of its Crop Science division, with Kelly Gast assuming
Read More